chronic

Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks. But our research team has found that thinking about the root cause of pain as a…

FEDERAL WAY, Wash., Sept. 05, 2023 (GLOBE NEWSWIRE) -- The Institute for Functional Medicine (IFM) welcomes results of a major new public health study, published in JAMA Internal Medicine, showing that intensive lifestyle interventions…

With the start of a new school year comes the inevitable battle to get kids back into a healthy bedtime routine. In many cases, this likely means resetting boundaries on screen use, especially late in the evenings. But imposing and…

Researchers at NYU College of Dentistry's Pain Research Center have developed a gene therapy that treats chronic pain by indirectly regulating a specific sodium ion channel, according to a new study published in the Proceedings of the…

A new review paper co-authored by two Johns Hopkins pain experts suggests that scrambler therapy, a noninvasive pain treatment, can yield significant relief for approximately 80%-90% of patients with chronic pain, and it may be more…

Pune, India, July 31, 2023 (GLOBE NEWSWIRE) -- The chronic lower back pain treatment market size was valued at USD 2.21 billion in 2022 and is projected to reach a valuation of USD 2.40 billion in 2023. The market is expected to reach…

Neuropathic pain is a debilitating condition estimated to affect as much as 10% of the global population. It results from a damaged or malfunctioning nervous system, stemming from diseases like diabetes, alcoholism, strokes, Parkinson's and…

Pune, India, July 26, 2023 (GLOBE NEWSWIRE) -- The global chronic wound care market size was valued at USD 12.48 billion in 2022. The market is projected to grow from USD 13.29 billion in 2023 to USD 21.00 billion by 2030, exhibiting a…

Wilmington, Delaware, United States, July 20, 2023 (GLOBE NEWSWIRE) -- The global chronic pelvic pain treatment market stood at US$ 5.7 billion in 2021, and the global market is projected to reach US$ 8.0 billion by 2031. The global…

FOSTER CITY, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to…